AETHLON MEDICAL INC 8-K
Research Summary
AI-generated summary
Aethlon Medical: Pre-Funded Warrants Exercised; 1,569,110 Shares Outstanding
What Happened Aethlon Medical, Inc. filed a Form 8-K (Item 8.01) on March 17, 2026, reporting that following recent exercises of its pre-funded warrants, all previously outstanding pre-funded warrants have been exercised. As of the close of business on March 16, 2026, Aethlon had 1,569,110 shares of common stock outstanding.
Key Details
- Filing: Form 8-K (Item 8.01) filed March 17, 2026.
- Shares outstanding: 1,569,110 common shares as of March 16, 2026.
- Warrants: All previously outstanding pre-funded warrants have been exercised (no pre-funded warrants remain outstanding).
Why It Matters This update changes the company’s reported number of common shares outstanding, which is a basic element used to calculate per-share metrics such as earnings per share and ownership percentages. The exercise of pre-funded warrants converts those instruments into common stock, eliminating that particular warrant overhang and increasing the share count to the stated level. Investors tracking dilution, voting power, or per-share figures should use the updated share count disclosed in this 8-K.
Loading document...